The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Neurocrine Biosciences, Inc(NASDAQ:NBIX) 
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...
Website: http://www.neurocrine.com
Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology
Neurocrine Biosciences Days Payable Outstanding ttm (DPO)
Neurocrine Biosciences Days Receivable Outstanding ttm (DSO)
Neurocrine Biosciences Days Inventory Outstanding ttm (DIO)
Neurocrine Biosciences Op Cashflow Per Share ttm
Neurocrine Biosciences Free Cashflow Per Share ttm
Neurocrine Biosciences Cash Per Share ttm
Neurocrine Biosciences P/S ratio ttm
Neurocrine Biosciences (GAAP) P/E ratio ttm
Neurocrine Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.